Immunomodulatory Therapy for Vogt-Koyanagi-Harada Patients as First-Line Therapy

ISSN： 0927-3948

Source： Ocular Immunology and Inflammation, Vol.14, Iss.2, 2006-03, pp. : 87-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infliximab Therapy for 2 Patients with Vogt-Koyanagi-Harada Syndrome

By Wang Yue Gaudio Paul

Ocular Immunology and Inflammation, Vol. 16, Iss. 4, 2008-08 ,pp. : 167-171

Informa Healthcare

Access to resources Recommend Favorite

Successful Use of Infliximab Therapy in Sight-threatening Corticosteroid-resistant Vogt-Koyanagi-Harada Disease

By Zmuda Mathieu Tiev Kiet Phong Knoeri Juliette Héron Emmanuel

Ocular Immunology and Inflammation, Vol. 21, Iss. 4, 2013-08 ,pp. : 310-316

Informa Healthcare

Access to resources Recommend Favorite

The Use of Low-Dose Azathioprine in Patients with Vogt-Koyanagi-Harada Disease

By Kim Sang Jin Yu Hyeong Gon

Ocular Immunology and Inflammation, Vol. 15, Iss. 5, 2007-09 ,pp. : 381-387

Informa Healthcare

Access to resources Recommend Favorite

HLA Typing in Vogt-Koyanagi-Harada Syndrome in North Indian Patients

By Gupta Amod Kamal Shivali Gupta Vishali Bambery Pradeep Kaura Babita

Ocular Immunology and Inflammation, Vol. 15, Iss. 2, 2007-03 ,pp. : 89-97

Informa Healthcare

Access to resources Recommend Favorite

Vogt-Koyanagi-Harada Disease in Thailand

By Yodmuang Tosaporn Rothova Aniki Kunavisarut Paradee Pathanapitoon Kessara

Ocular Immunology and Inflammation, Vol. 20, Iss. 6, 2012-12 ,pp. : 419-422

Informa Healthcare

Access to resources Recommend Favorite